Component

Autophagy activation

Autophagy activation. Species, exposure and limitations are retained in each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Intracellular bacterial infection decreases GABA levels in vitro in macrophages and in vivo in sera, treatment of macrophages with GABA or GABAergic drugs promotes autophagy activation, enhances phagosomal maturation and antimicrobial responses against mycobacterial infection, in macrophages the GABAergic defense is mediated via macrophage type A GABA receptor, intracellular calcium release and the GABA type A receptor-associated protein-like 1, and GABAergic inhibition increases bacterial loads in mice and zebrafish in vivo suggesting that the GABAergic defense plays an essential function in metazoan host defenses.

    Gamma-aminobutyric acid → Autophagy activation source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/gaba-research/30305619.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "4d53b15743f61b910fb1db4781905673c81a070c12245068a369548544e3bc6e", "start_char": 0, "end_char": 1146, "text_sha256": "4d53b15743f61b910fb1db4781905673c81a070c12245068a369548544e3bc6e"}
    experimental_model
    Autophagy and phagosome assays in macrophages with receptor and protein dependency, and infection burden in two whole animals
    exposure
    GABA and GABAergic drugs during intracellular mycobacterial infection, with GABAergic inhibition in vivo
    limitations
    The dependency on the receptor and on a specific autophagy protein is tested, and the outcome is measured in two species. The direction is the opposite of the autoimmunity records.
    nutrient_topic
    GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. · Gamma-aminobutyric acid
    organism
    Mouse and zebrafish
    plain_language
    Here the same molecule helps rather than suppresses: it drives the cell to digest the bacteria inside it, and blocking it lets the infection grow.
    primary_references
    [gb-p30305619] GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections. (2018). https://pubmed.ncbi.nlm.nih.gov/30305619/ DOI: 10.1038/s41467-018-06487-5
    tissue_or_cell_type
    Macrophage

    GABA: a ligand with no sign of its own, the cofactor that limits its synthesis, the barrier that keeps it out of the brain, and the immune settings where the same molecule protects and harms (2026-09-22) · lines 586–597

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Autophagy and phagosome assays in macrophages with receptor and protein dependency, and infection burden in two whole animals · source_derived_draft · unverified_draft

    ### gb-gaba-helps-the-host-kill-bacteria Intracellular bacterial infection decreases GABA levels in vitro in macrophages and in vivo in sera, treatment of macrophages with GABA or GABAergic drugs promotes autophagy activation, enhances phagosomal maturation and antimicrobial responses against mycobacterial infection, in macrophages the GABAergic defense is mediated via macrophage type A GABA receptor, intracellular calcium release and the GABA type A receptor-associated protein-like 1, and GABAergic inhibition increases bacterial loads in mice and zebrafish in vivo suggesting that the GABAergic defense plays an essential function in metazoan host defenses. Condition category: normal nutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. plain_language: Here the same molecule helps rather than suppresses: it drives the cell to digest the bacteria inside it, and blocking it lets the infection grow. organism: Mouse and zebrafish tissue_or_cell_type: Macrophage experimental_model: Autophagy and phagosome assays in macrophages with receptor and protein dependency, and infection burden in two whole animals limitations: The dependency on the receptor and on a specific autophagy protein is tested, and the outcome is measured in two species. The direction is the opposite of the autoimmunity records. exposure: GABA and GABAergic drugs during intracellular mycobacterial infection, with GABAergic inhibition in vivo evidence_span: {"source_cache": "artifacts/gaba-research/30305619.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "4d53b15743f61b910fb1db4781905673c81a070c12245068a369548544e3bc6e", "start_char": 0, "end_char": 1146, "text_sha256": "4d53b15743f61b910fb1db4781905673c81a070c12245068a369548544e3bc6e"} [gb-p30305619] GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections. (2018). https://pubmed.ncbi.nlm.nih.gov/30305619/ DOI: 10.1038/s41467-018-06487-5
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards